B. Cottier

1.8k total citations
18 papers, 1.3k citations indexed

About

B. Cottier is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, B. Cottier has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Radiation. Recurrent topics in B. Cottier's work include Lung Cancer Treatments and Mutations (6 papers), Advances in Oncology and Radiotherapy (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). B. Cottier is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Advances in Oncology and Radiotherapy (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). B. Cottier collaborates with scholars based in United Kingdom, Netherlands and Spain. B. Cottier's co-authors include Lesley Fairley, D Forman, James D. Thomas, Philip Quirke, Eva Morris, Germaine Heeren, Søren M. Bentzen, Walter Van den Bogaert, Ben J. Slotman and Yolande Lievens and has published in prestigious journals such as Journal of Clinical Oncology, Gut and British Journal of Cancer.

In The Last Decade

B. Cottier

18 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Cottier United Kingdom 12 818 711 341 310 278 18 1.3k
P. Thirion Ireland 15 619 0.8× 553 0.8× 205 0.6× 184 0.6× 302 1.1× 61 1.3k
Randall Hughes United States 15 631 0.8× 889 1.3× 251 0.7× 231 0.7× 261 0.9× 43 1.4k
Lucio Trodella Italy 22 721 0.9× 878 1.2× 353 1.0× 358 1.2× 535 1.9× 68 1.5k
Marie‐Cécile Bozonnat France 7 710 0.9× 1.6k 2.2× 414 1.2× 420 1.4× 159 0.6× 12 1.9k
Gabriel Boldt Canada 18 571 0.7× 950 1.3× 388 1.1× 351 1.1× 142 0.5× 89 1.5k
N. O’Rourke United Kingdom 16 651 0.8× 985 1.4× 351 1.0× 153 0.5× 404 1.5× 44 1.8k
Marc-André Mahé France 18 390 0.5× 768 1.1× 542 1.6× 350 1.1× 334 1.2× 89 1.4k
Marta Moreno Spain 17 449 0.5× 887 1.2× 490 1.4× 477 1.5× 308 1.1× 58 1.4k
Jose G. Bazan United States 22 545 0.7× 675 0.9× 355 1.0× 263 0.8× 472 1.7× 96 1.4k
Michael Johnston United States 5 503 0.6× 969 1.4× 127 0.4× 199 0.6× 342 1.2× 16 1.2k

Countries citing papers authored by B. Cottier

Since Specialization
Citations

This map shows the geographic impact of B. Cottier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Cottier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Cottier more than expected).

Fields of papers citing papers by B. Cottier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Cottier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Cottier. The network helps show where B. Cottier may publish in the future.

Co-authorship network of co-authors of B. Cottier

This figure shows the co-authorship network connecting the top 25 collaborators of B. Cottier. A scholar is included among the top collaborators of B. Cottier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Cottier. B. Cottier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Morris, Eva, D Forman, James D. Thomas, et al.. (2010). Surgical management and outcomes of colorectal cancer liver metastases. British journal of surgery. 97(7). 1110–1118. 274 indexed citations
3.
Morris, Eva, Philip Quirke, James D. Thomas, et al.. (2008). Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene?. Gut. 57(12). 1690–1697. 128 indexed citations
4.
James, Nicholas D., et al.. (2008). The Management of Interruptions to Radiotherapy in Head and Neck Cancer: An Audit of the Effectiveness of National Guidelines. Clinical Oncology. 20(8). 599–605. 14 indexed citations
5.
Ayres, Benjamin, et al.. (2007). 1052 RECENT TRENDS IN INCIDENCE AND MORTALITY OF PENILE CANCER IN ENGLAND. European Urology Supplements. 6(2). 285–285. 1 indexed citations
6.
Guedea, Ferrán, Jack Venselaar, Josep M. Borràs, et al.. (2006). Overview of brachytherapy resources in Europe: A survey of patterns of care study for brachytherapy in Europe. Radiotherapy and Oncology. 82(1). 50–54. 35 indexed citations
7.
Torrecilla, J. López, et al.. (2006). Patterns of care for brachytherapy in Europe results in Spain. Clinical & Translational Oncology. 8(5). 362–368. 7 indexed citations
8.
Bentzen, Søren M., Germaine Heeren, B. Cottier, et al.. (2005). Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project. Radiotherapy and Oncology. 75(3). 355–365. 176 indexed citations
9.
Slotman, Ben J., B. Cottier, Søren M. Bentzen, et al.. (2004). Overview of national guidelines for infrastructure and staffing of radiotherapy. ESTRO-QUARTS: Work package 1. Radiotherapy and Oncology. 75(3). 349.E1–349.E6. 138 indexed citations
10.
James, Nicholas D., et al.. (2003). A National Audit of Radiotherapy in Head and Neck Cancer. Clinical Oncology. 15(2). 41–46. 23 indexed citations
11.
Anderson, H, Penelope Hopwood, RJ Stephens, et al.. (2000). Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome. British Journal of Cancer. 83(4). 447–453. 251 indexed citations
12.
Chevalier, Thierry Le, Maya Gottfried, U. Gatzemeier, et al.. (1997). Etude multicentrique de phase II de la gemcitabine dans les cancers bronchiques non à petites cellules (CBNPC). Bulletin du Cancer. 84(3). 282–288. 1 indexed citations
13.
Anderson, Helén, B. Cottier, M. Nicolson, et al.. (1997). 24 Phase III study of gemcitabine (Gemzar®) versus best supportive care (BSC) in advanced non-small cell lung cancer (NSCLC). Lung Cancer. 18. 9–9. 21 indexed citations
14.
Lechevalier, T., Maya Gottfried, Frances A. Shepherd, et al.. (1997). [A phase II multicenter study of gemcitabine in non small cell lung cancers].. PubMed. 84(3). 282–8. 3 indexed citations
15.
Gatzemeier, U., Frances A. Shepherd, Thierry Le Chevalier, et al.. (1996). Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study. European Journal of Cancer. 32(2). 243–248. 204 indexed citations
16.
Jones, Bleddyn, et al.. (1995). The achievement of isoeffective bronchial mucosal dose during endobronchial brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 33(1). 195–199. 11 indexed citations
17.
Chevalier, Thierry Le, Maya Gottfried, U. Gatzemeier, et al.. (1993). Confirmatory activity of gemcitabine in non small cell lung cancer (NSCLC). European Journal of Cancer. 29. S160–S160. 9 indexed citations
18.
Clark, Peter & B. Cottier. (1992). The activity of 10-, 14-, and 21-day schedules of single-agent etoposide in previously untreated patients with extensive small cell lung cancer.. PubMed. 19(6 Suppl 14). 36–9. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026